Maxcyte (MXCT) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to -$0.12.
- Maxcyte's EPS (Weighted Average and Diluted) fell 909.09% to -$0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of -$0.39 for FY2024, which is 582.76% down from last year.
- Per Maxcyte's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.12 for Q3 2025, which was down 909.09% from -$0.12 recorded in Q2 2025.
- In the past 5 years, Maxcyte's EPS (Weighted Average and Diluted) registered a high of -$0.03 during Q3 2021, and its lowest value of -$0.12 during Q3 2025.
- In the last 5 years, Maxcyte's EPS (Weighted Average and Diluted) had a median value of -$0.09 in 2021 and averaged -$0.08.
- As far as peak fluctuations go, Maxcyte's EPS (Weighted Average and Diluted) surged by 5555.56% in 2022, and later plummeted by 16452.16% in 2023.
- Over the past 5 years, Maxcyte's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.05 in 2021, then dropped by 0.0% to -$0.05 in 2022, then grew by 0.0% to -$0.05 in 2023, then crashed by 102.14% to -$0.1 in 2024, then fell by 18.73% to -$0.12 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.12 for Q3 2025, versus -$0.12 for Q2 2025 and -$0.1 for Q1 2025.